Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

SCHERER CHARLES — Nautilus Biotechnology, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / SCHERER CHARLES

SCHERER CHARLES

Director at Nautilus Biotechnology, Inc. · on record since Aug 29, 2003

Insider trading activity of SCHERER CHARLES

Transactions on record: 2; since Aug 29, 2003

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 29, 2003

Figures computed from official regulatory filings — methodology.

Companies where SCHERER CHARLES has traded

Nautilus Biotechnology, Inc.2 tx · Aug 29, 2003

Track record of SCHERER CHARLES

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of SCHERER CHARLES

Co-insiders of SCHERER CHARLES

AH Bio Fund II-B, L.P.Nautilus Biotechnology, Inc.
AH Bio Fund II, L.P.Nautilus Biotechnology, Inc.
AH Equity Partners Bio II, L.L.C.Nautilus Biotechnology, Inc.
AH Equity Partners LSV II, L.L.C.Nautilus Biotechnology, Inc.
Akinsanya KarenNautilus Biotechnology, Inc.
ALTMAN MICHAEL SETHNautilus Biotechnology, Inc.
Andreessen Horowitz LSV Fund II-B, L.P.Nautilus Biotechnology, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Andreessen Horowitz LSV Fund II, L.P.Nautilus Biotechnology, Inc.

Andreessen Horowitz LSV Fund II-Q, L.P.Nautilus Biotechnology, Inc.

ANDREESSEN MARC LNautilus Biotechnology, Inc.

BANK ROBERT BNautilus Biotechnology, Inc.

CHU DAVIDNautilus Biotechnology, Inc.

EDELMAN JOSEPHNautilus Biotechnology, Inc.

Epperly Melissa B,Nautilus Biotechnology, Inc.

Godwin Mary E.Nautilus Biotechnology, Inc.

HOROWITZ BENJAMIN ANautilus Biotechnology, Inc.

Mallick ParagNautilus Biotechnology, Inc.

MARINO WAYNENautilus Biotechnology, Inc.

McIlwain Matthew SNautilus Biotechnology, Inc.

Mowry AnnaNautilus Biotechnology, Inc.

Murphy Matthew B.Nautilus Biotechnology, Inc.

NAZEM FARZADNautilus Biotechnology, Inc.

Nelson Nicholas A.Nautilus Biotechnology, Inc.

Pande Vijay SatyanandNautilus Biotechnology, Inc.

Patel Sujal MNautilus Biotechnology, Inc.

PERCEPTIVE ADVISORS LLCNautilus Biotechnology, Inc.

PERCEPTIVE LIFE SCIENCES MASTER FUND LTDNautilus Biotechnology, Inc.

PIPHER PAULETTE MCCREADYNautilus Biotechnology, Inc.

Posard Matthew L.Nautilus Biotechnology, Inc.

ROSENZWEIG ISRAELNautilus Biotechnology, Inc.

SANDERS HARVEYNautilus Biotechnology, Inc.

Sankar SubramanianNautilus Biotechnology, Inc.

Suzuki KentaroNautilus Biotechnology, Inc.

TISHMAN STEVENNautilus Biotechnology, Inc.

VARATOS JOHNNautilus Biotechnology, Inc.

V F CORPNautilus Biotechnology, Inc.

WEINER RONALDNautilus Biotechnology, Inc.

Weld Gwen ENautilus Biotechnology, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Nautilus Biotechnology, Inc.	Aug 29, 2003	Other	-1,000	17.00 USD	—	SEC
Nautilus Biotechnology, Inc.	Aug 29, 2003	OtherD	-8,000	—	—	SEC